Transglutaminase 2: A Novel Autoantigen in Canine Idiopathic Central Nervous System Inflammatory Diseases (original) (raw)

Transglutaminase 2 in human diseases

Zsolt Sarang

BioMedicine, 2017

View PDFchevron_right

Transglutaminase type II is involved in the pathogenesis of endotoxic shock

Loretta Tuosto

2008

View PDFchevron_right

Transglutaminase 6 antibodies in gluten neuropathy

Daniel Aeschlimann

Digestive and Liver Disease

View PDFchevron_right

Tissue transglutaminase: A novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases

benjamin drukarch

European Journal of Pharmacology, 2008

View PDFchevron_right

Experience with newer central nervous system autoantibodies

Abid Karim

Annals of Clinical Biochemistry, 2017

View PDFchevron_right

Transglutaminases: part I—origins, sources, and biotechnological characteristics

Carla Matte

World Journal of Microbiology and Biotechnology, 2020

View PDFchevron_right

Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis

Sarolta Kárpáti

2000

View PDFchevron_right

Identification of Tissue Transglutaminase as a Novel Molecule Involved In Human CD8+ T Cell Transendothelial Migration

Bela Rex-Kiss

The Journal of Immunology, 2003

View PDFchevron_right

Expression of Transglutaminase 5 in Normal and Pathologic Human Epidermis

alessandro terrinoni

Journal of Investigative Dermatology, 2002

View PDFchevron_right

Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter

benjamin drukarch

PLoS ONE, 2014

View PDFchevron_right

Physiopathological roles of human transglutaminase 2

Vittorio Gentile

Advances in enzymology and related areas of molecular biology, 2011

View PDFchevron_right

Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease

Detlef Schuppan

Journal of the American Academy of Dermatology, 1999

View PDFchevron_right

The role of transglutaminase in the mechanism of action of tetanus toxin

Julie Coffield

Journal of Biological Chemistry, 1994

View PDFchevron_right

Glucose Homeostasis in Mice Is Transglutaminase 2 Independent

Siiri Iismaa

PLoS ONE, 2013

View PDFchevron_right

The cellular response to transglutaminase-cross-linked collagen

Victoria Addy

Biomaterials, 2005

View PDFchevron_right

Antibodies to Tissue Transglutaminase as Serologic Markers in Patients with Dermatitis Herpetiformis

Sarolta Kárpáti

Journal of Investigative Dermatology, 1999

View PDFchevron_right

Autoimmune diseases - New insights into a troublesome field

Martin Risch

Journal of Translational Autoimmunity, 2021

View PDFchevron_right

Tissue transglutaminase modulates α-synuclein oligomerization

benjamin drukarch

Protein Science, 2008

View PDFchevron_right

Prognostic role of tissue transglutaminase 2 in colon carcinoma

Sofia Ángel Torres

Virchows Archiv, 2016

View PDFchevron_right

Anti-LGI1 autoimmune encephalitis in a patient with rheumatoid arthritis and MGUS

Aimilios Kaklamanos

European journal of case reports in internal medicine, 2024

View PDFchevron_right

Autoimmune Limbic Encephalitis Associated with Glutamic Acid Decarboxylase Antibodies

Krishnan balagopal

Journal of evolution of medical and dental sciences, 2021

View PDFchevron_right

Lung inflammation regulates autoimmunity in the central nervous system

Mari Shinohara

Journal of Neurology and Neuromedicine, 2016

View PDFchevron_right

Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival?

Jatinder Kaur

Annals of Hepato-Biliary-Pancreatic Surgery, 2020

View PDFchevron_right

A case of stiff dog syndrome associated with anti-glutamic acid decarboxylase antibodies

John Rossmeisl

Journal of clinical movement disorders, 2017

View PDFchevron_right

The role of transglutaminase-2 and its substrates in human diseases

Antonio Facchiano

Frontiers in Bioscience, 2006

View PDFchevron_right

Differential expression of tissue transglutaminase in human cells

Anne-marie Van Dam

Cell And Tissue Research, 1989

View PDFchevron_right

Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease

Gerda Andringa

The FASEB Journal, 2004

View PDFchevron_right

Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects

Simone Beninati

The Biochemical journal, 2018

View PDFchevron_right

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases

Gabriela Kocurova

Theranostics

View PDFchevron_right

Can tissue transglutaminase be a marker of idiopathic inflammatory myopathies?

Ewa G Gendek, Hanna Gendek-Kubiak

Immunology Letters, 2005

View PDFchevron_right

Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity

benjamin drukarch

Neurobiology of Disease

View PDFchevron_right

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

Theresa Wampler Muskardin

Journal of Clinical Investigation, 2019

View PDFchevron_right

Transglutaminase 2 Contributes to Apoptosis Induction in Jurkat T Cells by Modulating Ca2+ Homeostasis via Cross-Linking RAP1GDS1

Jiann-jou Yang

PLoS ONE, 2013

View PDFchevron_right

A Candidate Gene Study of Canine Joint Diseases

Bill Ollier

Journal of Heredity, 2009

View PDFchevron_right

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

Eitan Israeli

Clinical Reviews in Allergy & Immunology, 2010

View PDFchevron_right